Recurrent chondromyxoid fibroma of the distal femur treated with percutaneous cryoablation.
Chondromyxoid fibroma
Distal femur
Percutaneous cryoablation
Journal
Skeletal radiology
ISSN: 1432-2161
Titre abrégé: Skeletal Radiol
Pays: Germany
ID NLM: 7701953
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
02
05
2023
accepted:
24
07
2023
revised:
28
06
2023
medline:
23
10
2023
pubmed:
7
8
2023
entrez:
6
8
2023
Statut:
ppublish
Résumé
Chondromyxoid fibroma is a rare, benign tumor of the bone with excellent prognosis but a high rate of recurrence. We report a patient presenting with pain and a history of chondromyxoid fibroma of the distal left femur previously treated with multiple prior curettage and bone graft procedures. Magnetic resonance imaging and histopathology indicated a recurrence of tumor. Due to the small size of the tumor recurrence and challenges associated with prior open surgery, the patient underwent cryoablation of the lesion with computed tomography guidance. Follow-up 18 months later indicated a resolution of pain and improvement on magnetic resonance imaging, and no concerns after 20 months. To our knowledge, this is the first reported case of chondromyxoid fibroma treated with cryoablation. This case suggests cryoablation could be considered in the setting of recurrent chondromyxoid fibroma for local tumor control.
Identifiants
pubmed: 37544967
doi: 10.1007/s00256-023-04414-4
pii: 10.1007/s00256-023-04414-4
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2497-2501Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2023. The Author(s), under exclusive licence to International Skeletal Society (ISS).
Références
Jaffe HL, Lichtenstein L. Chondromyxoid fibroma of bone; a distinctive benign tumor likely to be mistaken especially for chondrosarcoma. Arch Pathol. 1948;45(4):541–51.
Tu WC, Inwards CY, O’laughlin S, Rock MG, Beabout JW, Unni KK. Chondromyxoid fibroma of bone: a clinicopathologic review of 278 cases. Hum Pathol. 1998;29(5):438–46.
doi: 10.1016/S0046-8177(98)90058-2
Heck RK, Toy PC, et al. Benign/aggressive tumors of bone. In: Azar FM, Beaty JH, et al., editors. Campbell’s Operative Orthopaedics. 13th ed. Philadelphia: Elsevier; 2017. p. 923–44.e3.
Cappelle S, Pans S, Sciot R. Imaging features of chondromyxoid fibroma: report of 15 cases and literature review. Br J Radiol. 2016;89(1064):20160088.
doi: 10.1259/bjr.20160088
pubmed: 27226218
pmcid: 5124884
Yalniz E, Alicioglu B, Yalcin O, Yilmaz B. Non specific magnetic resonance features of chondromyxoid fibroma of the iliac bone. Journal of BU ON. 2007;12(3):407–9.
Mitchell M, Sartoris DJ, Resnick D. Case report 713. Chondromyxoid fibroma of the third metatarsal. Skeletal Radiol. 1992;21(4):252–5.
pubmed: 1626293
Layfield LJ. Cytopathology of bone and soft tissue tumors. Oxford: Oxford Univ. Press; 2002.
Damle RP, Suryawanshi KH, Dravid NV, Gadre A, Borse YM. Chondromyxoid fibroma of bone. Journal of Case Reports. 2013;3(2):228–31.
doi: 10.17659/01.2013.0054
Schajowicz F, Gallardo H. Chondromyxoid fibroma (fibromyxoid chondroma) of bone. A clinico-pathological study of thirty-two cases. J Bone and Joint Surg Br Vol. 1971;53(2):198–216.
doi: 10.1302/0301-620X.53B2.198
Rahimi A, Beabout JW, Ivins JC, Dahlin DC. Chondromyxoid fibroma: a clinicopathologic study of 76 cases. Cancer. 1972;30(3):726–36.
doi: 10.1002/1097-0142(197209)30:3<726::AID-CNCR2820300321>3.0.CO;2-T
pubmed: 5075357
Horstmann PF, Hettwer WH, Petersen MM. Treatment of benign and borderline bone tumors with combined curettage and bone defect reconstruction. J Orthop Surg. 2018;26(3):2309499018774929.
doi: 10.1177/2309499018774929
Berenstein-Weyel T, Lebel E, Katz D, Applbaum Y, Peyser A. Chondromyxoid fibroma of the distal fibula treated by percutaneous radiofrequency ablation. J Orthop Surg. 2017;25(2):2309499017720830.
doi: 10.1177/2309499017720830
Foster RCB, Stavas JM. Bone and soft tissue ablation. Semin Interv Radiol. 2014;31(2):167–79.
doi: 10.1055/s-0034-1373791
Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
doi: 10.1038/nrc3672
pubmed: 24561446
Tomasian A, Cazzato RL, Sharma K, Gangi A, Jennings JW. Benign bone tumors: state of the art in minimally invasive percutaneous interventions. Radiographics. 2023;43(2):e220041.
doi: 10.1148/rg.220041
pubmed: 36563097
Le Corroller T, Vives T, Mattei J, Pauly V, Guenoun D, Rochwerger A, et al. Osteoid osteoma: percutaneous CT-guided cryoablation is a safe, effective, and durable treatment option in adults. Radiology. 2022;302(2):392–9.
doi: 10.1148/radiol.2021211100
pubmed: 34812672
Colangeli S, Parchi P, Andreani L, Beltrami G, Scoccianti G, Sacchetti F, et al. Cryotherapy efficacy and safety as local therapy in surgical treatment of musculoskeletal tumours. A retrospective case series of 143 patients. J Biol Regul Homeost Agents. 2018;32(6 Suppl. 1):65–70.
pubmed: 30644284
Fritz J, Sonnow L, Morris CD. Adjuvant MRI-guided percutaneous cryoablation treatment for aneurysmal bone cyst. Skeletal Radiol. 2019;48(7):1149–53.
doi: 10.1007/s00256-018-3115-1
pubmed: 30523379
Zivin SP, Gaba RC. Technical and practical considerations for device selection in locoregional ablative therapy. Semin Interv Radiol. 2014;31(2):212–24.
doi: 10.1055/s-0034-1373796
Callstrom M, Kurup A. Percutaneous ablation for bone and soft tissue metastases—why cryoablation? Skeletal Radiol. 2009;38(9):835–9.
doi: 10.1007/s00256-009-0736-4
pubmed: 19590871
Auloge P, Cazzato RL, Rousseau C, Caudrelier J, Koch G, Rao P, et al. Complications of percutaneous bone tumor cryoablation: a 10-year experience. Radiology. 2019;291(2):521–8.
doi: 10.1148/radiol.2019181262
pubmed: 30806603